Weinberger M H
Am J Med. 1987 Jan 5;82(1A):44-9. doi: 10.1016/0002-9343(87)90143-4.
Due to the potency and multiple actions of available agents, current antihypertensive therapy can control blood pressure in virtually every patient with hypertension. In the past, physicians were primarily concerned with blood pressure reduction; the side effects of antihypertensive agents were a matter of lesser concern. Today, however, drugs can be selected for therapy on the basis of providing optimal antihypertensive efficacy and minimal harmful side effects. Furthermore, now that blood pressure can be effectively managed and the overall incidence of stroke has been reduced, perhaps the aim of therapy in patients with hypertension should include the reduction of coronary heart disease incidence. Three broad categories of antihypertensive agents are available: diuretics, antisympathetic agents, and vasodilators. Each class of drugs has its own pattern of action and produces optimal efficacy in identifiable patient populations, and each has a distinct side-effect profile. Knowledge of these variables and a scheme that can identify patients likely to benefit from a specific agent are paramount considerations in the treatment of hypertension.
由于现有药物的效力和多种作用,目前的抗高血压治疗实际上可以控制每一位高血压患者的血压。过去,医生主要关注血压降低;抗高血压药物的副作用则较少受到关注。然而如今,可以根据提供最佳抗高血压疗效和最小有害副作用来选择药物进行治疗。此外,既然血压能够得到有效控制且中风的总体发病率已经降低,那么高血压患者的治疗目标或许应该包括降低冠心病发病率。有三大类抗高血压药物:利尿剂、抗交感神经药物和血管扩张剂。每一类药物都有其自身的作用模式,在特定患者群体中产生最佳疗效,并且每一类都有独特的副作用谱。了解这些变量以及一种能够识别可能从特定药物中获益的患者的方案,是高血压治疗中的首要考虑因素。